概括
费布里病是一种罕见的遗传疾病,需要早期查和多学科护理. 这项研究为中国临床医生提供了关于启动酶替代疗法和监测酶替代疗法的指导.
科学领域:
- 遗传学和罕见疾病.
- 酶替代疗法是一种酶替代疗法.
- 临床管理的临床管理.
背景情况:
- 费布里病是一种罕见的X链遗传性疾病,由α-银酸酶A (GLA) 基因突变引起.
- 降低的α-galactosidase A酶活性导致各种临床表现,经常导致诊断延迟和增加患者负担.
- 涉及各种专业的多学科治疗 (MDT) 对于管理法布里病至关重要.
研究的目的:
- 为中国临床医生提供关于管理法布里病的实际指导.
- 专注于Fabry病的早期查策略.
- 概述酶替代疗法 (ERT) 的指示,治疗前的评估和监测协议.
主要方法:
- 关于法布里病诊断和管理的文献综述.
- 分析当前的临床实践和指导方针.
- 为早期查和ERT启动制定建议.
主要成果:
- 早期查对于及时诊断法布里病至关重要.
- 已经确立了启动酶替代疗法的明确指示.
- 详细介绍了治疗前评估和持续监测协议.
结论:
- 早期检测和全面的,多学科的管理对于改善法布里病的结果至关重要.
- 本指南旨在支持中国临床医生优化对法布里病患者的护理.
- 有效的管理包括及时的ERT和对疾病进展的警监测.
更多相关视频
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
6.3K
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.5K
相关概念视频
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
